Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Compass Therapeutics (CMPX) Return on Equity: 2023-2025

Historic Return on Equity for Compass Therapeutics (CMPX) over the last 2 years, with Sep 2025 value amounting to -0.46%.

  • Compass Therapeutics' Return on Equity fell 11.00% to -0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.46%, marking a year-over-year decrease of 11.00%. This contributed to the annual value of -0.41% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Compass Therapeutics' Return on Equity stood at -0.46%, which was up 29.19% from -0.65% recorded in Q2 2025.
  • Compass Therapeutics' 5-year Return on Equity high stood at -0.28% for Q4 2023, and its period low was -0.65% during Q2 2025.
  • For the 3-year period, Compass Therapeutics' Return on Equity averaged around -0.41%, with its median value being -0.37% (2024).
  • Data for Compass Therapeutics' Return on Equity shows a maximum YoY tumbled of 34bps (in 2025) over the last 5 years.
  • Compass Therapeutics' Return on Equity (Quarterly) stood at -0.28% in 2023, then declined by 12bps to -0.40% in 2024, then dropped by 11bps to -0.46% in 2025.
  • Its last three reported values are -0.46% in Q3 2025, -0.65% for Q2 2025, and -0.50% during Q1 2025.